The ACHIEVE study, funded by CEPI with $10.3M, aims to estimate chikungunya cases in Kenya and Tanzania, starting spring 2025. Led by Oxford's Centre for Tropical Medicine, it seeks to improve understanding of the disease's burden and inform vaccine development and deployment strategies.